Korean J Hepatol.  2002 Sep;8(3):317-320.

A Case of Acute Cholestatic Hepatitis Associated with Orlistat

Affiliations
  • 1Department of Gastroenterology, Ajou University College of Medicine, Suwon, Korea. sung-woncho@hotmail.com
  • 2Department of Histopathology, Ajou University College of Medicine, Suwon, Korea.

Abstract

Orlistat(Xenical(R), Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have been published except a case of subacute hepatic failure leading to liver transplantation in a young women with moderate obesity treated with orlistat. We report a case of acute cholestatic hepatitis in a young woman with moderate obesity treated with orlistat: a 33-year-old female admitted for the evaluation of jaundice. Abdominal ultrasonography, ERCP, routine chemistry, viral markers, and a fine needle biopsy of liver were performed. Microscopic findings of the liver biopsy specimen were compatible with acute cholestatic hepatitis. After steroid therapy, liver function was improved.

Keyword

Orlistat; Acute cholestatic hepatitis; Side effect

MeSH Terms

Acute Disease
Adult
Anti-Obesity Agents/*adverse effects
Cholestasis/*chemically induced/diagnosis
English Abstract
Female
Hepatitis, Toxic/*diagnosis/etiology
Human
Lactones/*adverse effects
Lipase/antagonists & inhibitors
Full Text Links
  • KJHEP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr